FENC
FENNEC PHARMACEUTICALS INC.
+0.30 (+2.84%)10.85USD34.7K成交股數380M市值–本益比(近四季)6.4股價營收比+85.2%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 17.9M+85% | 15.1M+73% | 13.8M+98% | 12.5M+72% | 9.7M-62% | 8.8M-10% | 7.0M+7% | 7.3M+118% | 25.4M | 9.7M | 6.5M | 3.3M |
| 營業成本 | – | – | – | – | – | – | – | – | – | 685K | 331K | 148K |
| 毛利 | – | – | – | – | – | – | – | – | – | 9.1M | 6.2M | 3.2M |
| 毛利率 | – | – | – | – | – | – | – | – | – | 93.0% | 94.9% | 95.5% |
| 研發費用 | 118K | 49K | 20K | 29K | 107K | 94K | 97K | 157K | 3K | 32K | 12K | 8K |
| 銷售管理費用 | 4.6M | 3.2M | 9.2M | 6.8M | 6.5M | 5.9M | 6.1M | 6.9M | 5.9M | 7.0M | 3.8M | 5.5M |
| 營業利益 | 1.7M-164% | −119K-85% | −2.6M-51% | −189K-96% | −2.7M-120% | −808K-56% | −5.2M+412% | −5.0M+8% | 13.7M | −1.8M | −1.0M | −4.7M |
| 營業利益率 | 9.7% | -0.8% | -18.5% | -1.5% | -28.3% | -9.2% | -74.6% | -69.4% | 54.2% | -18.7% | -15.6% | -140.3% |
| 稅後淨利 | 2.0M-163% | 201K-117% | −9.7B+169665% | −638K-89% | −3.2M-125% | −1.2M-100% | −5.7M+207% | −5.6M+2% | 12.8M | −16.0B | −1.9M | −5.4M |
| 淨利率 | 11.0% | 1.3% | -70,668.8% | -5.1% | -32.7% | -13.3% | -82.2% | -76.5% | 50.6% | -164,680.4% | -28.7% | -163.7% |
| 稀釋 EPS | 0.05-145% | 0.01-125% | -0.17-19% | -0.02-90% | -0.11-127% | -0.04-56% | -0.21+200% | -0.20-5% | 0.41 | -0.09 | -0.07 | -0.21 |
| 稀釋股數 | 36.4M | 35.5M | 28.6M | 27.9M | 27.7M | 27.6M | 27.4M | 27.3M | 31.1M | 26.6M | 26.6M | 26.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 41.2M | 40.2M | 36.8M | 21.9M | 18.7M | 22.7M | 40.3M | 43.1M | 51.2M | 13.3M | 12.4M | 15.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 75.8M | 71.8M | 70.6M | 49.3M | 44.9M | 46.4M | 58.9M | 63.2M | 69.2M | 26.9M | 20.0M | 19.4M |
| 有息負債 | – | – | – | 19.4M | 19.4M | 19.4M | 32.1M | 31.8M | 31.3M | 30.9M | 25.6M | 25.4M |
| 總負債 | 33.3M | 34.1M | 35.1M | 53.8M | 52.3M | 52.3M | 64.1M | 64.5M | 66.2M | 38.5M | 29.6M | 29.2M |
| 股東權益 | 42.4M | 37.7M | 35.5M | −4.5M | −7.5M | −5.9M | −5.2M | −1.4M | 3.0M | −11.6M | −10.5M | −9.7M |
| 負債比 | 44.0% | 47.5% | 49.7% | 109.1% | 116.6% | 112.7% | 108.8% | 102.1% | 95.6% | 143.3% | 148.0% | 150.0% |
| 淨現金(現金 − 有息負債) | – | – | – | 2.6M | −659K | 3.3M | 8.2M | 11.3M | 19.8M | −17.7M | −13.2M | −10.4M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 2.4M-155% | – | – | – | −4.3M | – | – | 39.0M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 44.6M
| Pedmark | 44.6M | 100.0% | +50.9% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 44.6M | -6.1% | −9.7B | -21,820.3% | -0.34 | – |
| FY2024 | 47.5M | +123.7% | −436M | -917.2% | -0.02 | – |
| FY2023 | 21.3M | +1284.5% | −16.0B | -75,498.8% | -0.60 | – |
| FY2022 | 1.5M | – | −23.7M | -1,544.9% | -0.90 | – |
| FY2021 | – | – | −17.3M | –% | -0.67 | – |
| FY2020 | 200K | – | −18.1M | -9,054.5% | -0.76 | – |
| FY2019 | 0.00 | – | −12.8M | –% | -0.64 | – |
| FY2018 | 0.00 | – | −9.9M | –% | -0.52 | – |